Robert A. Blum

3.2k total citations
83 papers, 2.4k citations indexed

About

Robert A. Blum is a scholar working on Pharmacology, Surgery and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Robert A. Blum has authored 83 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pharmacology, 14 papers in Surgery and 13 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Robert A. Blum's work include Antibiotics Pharmacokinetics and Efficacy (12 papers), Pharmacogenetics and Drug Metabolism (10 papers) and Pharmacological Effects and Toxicity Studies (10 papers). Robert A. Blum is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (12 papers), Pharmacogenetics and Drug Metabolism (10 papers) and Pharmacological Effects and Toxicity Studies (10 papers). Robert A. Blum collaborates with scholars based in United States, United Kingdom and Austria. Robert A. Blum's co-authors include William J. Jusko, Christian D. Lates, Jerome J. Schentag, Keith A. Rodvold, Mindy Magee, Kent Crossley, Donald E. Mager, Louise J. Riff, John C. Rotschafer and Mark Gardner and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Internal Medicine and Journal of Neurophysiology.

In The Last Decade

Robert A. Blum

82 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert A. Blum United States 24 470 396 375 372 296 83 2.4k
James F. McLeod United States 28 234 0.5× 342 0.9× 274 0.7× 487 1.3× 460 1.6× 52 1.9k
Seo Hyun Yoon South Korea 25 349 0.7× 482 1.2× 169 0.5× 300 0.8× 453 1.5× 104 2.1k
William G. Kramer United States 31 384 0.8× 381 1.0× 347 0.9× 138 0.4× 739 2.5× 117 2.9k
Indravadan H. Patel United States 27 917 2.0× 381 1.0× 175 0.5× 230 0.6× 256 0.9× 75 2.4k
John H. Cavanaugh United States 23 222 0.5× 245 0.6× 201 0.5× 313 0.8× 156 0.5× 59 1.7k
Stéphane Mouly France 27 263 0.6× 364 0.9× 414 1.1× 99 0.3× 212 0.7× 99 2.4k
James Longstreth United States 23 601 1.3× 242 0.6× 88 0.2× 501 1.3× 415 1.4× 40 2.2k
David Hermann United States 23 285 0.6× 264 0.7× 1.1k 3.0× 366 1.0× 274 0.9× 46 3.6k
Marco Tuccori Italy 31 213 0.5× 507 1.3× 394 1.1× 146 0.4× 485 1.6× 110 2.7k
Frieder Kees Germany 31 1.1k 2.3× 225 0.6× 297 0.8× 172 0.5× 523 1.8× 139 3.2k

Countries citing papers authored by Robert A. Blum

Since Specialization
Citations

This map shows the geographic impact of Robert A. Blum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert A. Blum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert A. Blum more than expected).

Fields of papers citing papers by Robert A. Blum

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert A. Blum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert A. Blum. The network helps show where Robert A. Blum may publish in the future.

Co-authorship network of co-authors of Robert A. Blum

This figure shows the co-authorship network connecting the top 25 collaborators of Robert A. Blum. A scholar is included among the top collaborators of Robert A. Blum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert A. Blum. Robert A. Blum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sromicki, Juri, et al.. (2025). Early Vitrectomy in Endophthalmitis: Visual Outcomes and Complication Rates. Ophthalmology and Therapy. 14(8). 2031–2042.
2.
3.
4.
Blum, Robert A., Lik Thai Lim, & Clifford R. Weir. (2012). Diplopia following sub-tenon’s anaesthesia: an unusual complication. International Ophthalmology. 32(2). 191–193. 8 indexed citations
5.
Johnson, Brendan M., et al.. (2009). Impact of casopitant, a novel NK-1 antagonist, on the pharmacokinetics of ondansetron and dexamethasone. Supportive Care in Cancer. 17(9). 1177–1185. 14 indexed citations
6.
Hong, Ying, Donald E. Mager, Robert A. Blum, & William J. Jusko. (2007). Population Pharmacokinetic/Pharmacodynamic Modeling of Systemic Corticosteroid Inhibition of Whole Blood Lymphocytes: Modeling Interoccasion Pharmacodynamic Variability. Pharmaceutical Research. 24(6). 1088–1097. 20 indexed citations
7.
Lee, Yih, Anup Majumdar, Kevin J. Petty, et al.. (2004). Evaluation of Potential Inductive Effects of Aprepitant on Cytochrome P450 3A4 and 2C9 Activity. The Journal of Clinical Pharmacology. 44(3). 215–223. 88 indexed citations
8.
Mager, Donald E., et al.. (2003). Dose Equivalency Evaluation of Major Corticosteroids: Pharmacokinetics and Cell Trafficking and Cortisol Dynamics. The Journal of Clinical Pharmacology. 43(11). 1216–1227. 125 indexed citations
9.
Miller, Ann K., et al.. (2003). Pharmacokinetics of Rosiglitazone in Patients with Varying Degrees of Renal Insufficiency. The Journal of Clinical Pharmacology. 43(3). 252–259. 68 indexed citations
10.
Magee, Mindy, Robert A. Blum, Christian D. Lates, & William J. Jusko. (2002). Pharmacokinetic/pharmacodynamic model for prednisolone inhibition of whole blood lymphocyte proliferation. British Journal of Clinical Pharmacology. 53(5). 474–484. 38 indexed citations
11.
Marbury, Thomas, et al.. (2002). Pharmacokinetics and Safety of a Single Oral Dose of Once‐Daily Alfuzosin, 10 mg, in Male Subjects with Mild to Severe Renal Impairment. The Journal of Clinical Pharmacology. 42(12). 1311–1317. 8 indexed citations
12.
Blum, Robert A., et al.. (2001). Effects of Oral Prasterone (Dehydroepiandrosterone) on Single‐Dose Pharmacokinetics of Oral Prednisone and Cortisol Suppression in Normal Women. The Journal of Clinical Pharmacology. 41(11). 1195–1205. 20 indexed citations
13.
Chakraborty, Abhijit, Robert A. Blum, David L. Cutler, & William J. Jusko. (1999). Pharmacoimmunodynamic interactions of interleukin-10 and prednisone in healthy volunteers. Clinical Pharmacology & Therapeutics. 65(3). 304–318. 24 indexed citations
14.
Chakraborty, Abhijit, et al.. (1999). Pharmacokinetic and Adrenal Interactions of IL‐10 and Prednisone in Healthy Volunteers. The Journal of Clinical Pharmacology. 39(6). 624–635. 23 indexed citations
15.
Thompson, Keith, et al.. (1999). Effect of hepatic impairment on the pharmacokinetics of rosiglitazone. Clinical Pharmacology & Therapeutics. 65(2). 186. 3 indexed citations
16.
Troy, Steven, Robert W. Schultz, Vernon D. Parker, Soong T. Chiang, & Robert A. Blum. (1994). The effect of renal disease on the disposition of venlafaxine. Clinical Pharmacology & Therapeutics. 56(1). 14–21. 44 indexed citations
17.
Blum, Robert A., et al.. (1991). Effect of fluconazole on the disposition of phenytoin. Clinical Pharmacology & Therapeutics. 49(4). 420–425. 91 indexed citations
18.
Blum, Robert A., et al.. (1991). Increased Gastric pH and the Bioavailability of Fluconazole and Ketoconazole. Annals of Internal Medicine. 114(9). 755–757. 134 indexed citations
19.
Blum, Robert A., et al.. (1990). Pharmacokinetics of Quinapril and Its Active Metabolite, Quinaprilat, in Patients on Chronic Hemodialysis. The Journal of Clinical Pharmacology. 30(10). 938–942. 16 indexed citations
20.
Rodvold, Keith A., Robert A. Blum, Louise J. Riff, et al.. (1989). Simulation of Vancomycin Peak and Trough Concentrations Using Five Dosing Methods in 37 Patients. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 9(1). 10–16. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by James F. McLeod Breakdown of academic impact, for papers by Seo Hyun Yoon Breakdown of academic impact, for papers by William G. Kramer Breakdown of academic impact, for papers by Indravadan H. Patel Breakdown of academic impact, for papers by John H. Cavanaugh Breakdown of academic impact, for papers by Stéphane Mouly Breakdown of academic impact, for papers by James Longstreth Breakdown of academic impact, for papers by David Hermann Breakdown of academic impact, for papers by Marco Tuccori Breakdown of academic impact, for papers by Frieder Kees
Rankless by CCL
2026